MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
Log in

NASDAQ:ONCYOncolytics Biotech News Headlines

$2.34
-0.14 (-5.65 %)
(As of 05/29/2020 11:00 AM ET)
Add
Compare
Today's Range
$2.33
Now: $2.34
$2.58
50-Day Range
$1.33
MA: $1.78
$2.66
52-Week Range
$0.35
Now: $2.34
$6.02
Volume396,298 shs
Average Volume1.64 million shs
Market Capitalization$86.73 million
P/E RatioN/A
Dividend YieldN/A
Beta2.48

Headlines

Oncolytics Biotech (NASDAQ ONCY) News Headlines

Source:
DateHeadline
Oncolytics Biotech, Inc. (NASDAQ:ONCY) Short Interest UpdateOncolytics Biotech, Inc. (NASDAQ:ONCY) Short Interest Update
www.americanbankingnews.com - May 22 at 5:18 PM
Zacks: Brokerages Anticipate Oncolytics Biotech, Inc. (NASDAQ:ONCY) Will Post Earnings of -$0.15 Per ShareZacks: Brokerages Anticipate Oncolytics Biotech, Inc. (NASDAQ:ONCY) Will Post Earnings of -$0.15 Per Share
www.americanbankingnews.com - May 22 at 3:51 PM
Oncolytics Biotech, Inc. (NASDAQ:ONCY) Sees Large Drop in Short InterestOncolytics Biotech, Inc. (NASDAQ:ONCY) Sees Large Drop in Short Interest
www.americanbankingnews.com - May 16 at 7:54 AM
Canaccord Genuity Reaffirms Buy Rating for Oncolytics Biotech (NASDAQ:ONCY)Canaccord Genuity Reaffirms Buy Rating for Oncolytics Biotech (NASDAQ:ONCY)
www.americanbankingnews.com - May 15 at 5:11 PM
Oncolytics Biotech® to Present at the RBC Global Healthcare ConferenceOncolytics Biotech® to Present at the RBC Global Healthcare Conference
finance.yahoo.com - May 13 at 7:17 AM
Oncolytics Biotech (NASDAQ:ONCY) Receives "Buy" Rating from Roth CapitalOncolytics Biotech (NASDAQ:ONCY) Receives "Buy" Rating from Roth Capital
www.americanbankingnews.com - May 12 at 1:33 AM
Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $6.00Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $6.00
www.americanbankingnews.com - May 11 at 6:31 PM
Oncolytics Biotech EPS beats by $0.10Oncolytics Biotech EPS beats by $0.10
seekingalpha.com - May 8 at 7:30 AM
Oncolytics Biotech® Reports 2020 First Quarter Financial Results and Operational HighlightsOncolytics Biotech® Reports 2020 First Quarter Financial Results and Operational Highlights
finance.yahoo.com - May 8 at 7:30 AM
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of ShareholdersOncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
finance.yahoo.com - May 8 at 7:30 AM
Oncolytics Biotech® to Present Clinical Findings of Pelareorep-Induced Immune Response in Breast Tumors at the ESMO Breast Cancer Virtual MeetingOncolytics Biotech® to Present Clinical Findings of Pelareorep-Induced Immune Response in Breast Tumors at the ESMO Breast Cancer Virtual Meeting
finance.yahoo.com - May 4 at 9:20 AM
Oncolytics Biotech® Announces Changes to Annual General MeetingOncolytics Biotech® Announces Changes to Annual General Meeting
finance.yahoo.com - April 30 at 7:24 AM
Oncolytics Biotech Updates Clinical Development and Operations Activities During the COVID-19 PandemicOncolytics Biotech Updates Clinical Development and Operations Activities During the COVID-19 Pandemic
www.finanznachrichten.de - April 19 at 5:50 PM
Oncolytics Biotech® Updates Clinical Development and Operations Activities During the COVID-19 PandemicOncolytics Biotech® Updates Clinical Development and Operations Activities During the COVID-19 Pandemic
finance.yahoo.com - April 17 at 7:32 PM
Have Insiders Been Buying Oncolytics Biotech Inc. (TSE:ONC) Shares?Have Insiders Been Buying Oncolytics Biotech Inc. (TSE:ONC) Shares?
finance.yahoo.com - April 15 at 2:14 PM
Oncolytics Biotech® Announces Publication of Pelareorep's Clinical Benefit Against KRAS Mutated Colorectal CancerOncolytics Biotech® Announces Publication of Pelareorep's Clinical Benefit Against KRAS Mutated Colorectal Cancer
finance.yahoo.com - April 2 at 11:14 AM
Oncolytics Biotech® Announces Favourable AWARE-1 Safety UpdateOncolytics Biotech® Announces Favourable AWARE-1 Safety Update
finance.yahoo.com - March 24 at 7:49 AM
Oncolytics Biotech, Inc. to Host Earnings CallOncolytics Biotech, Inc. to Host Earnings Call
finance.yahoo.com - March 5 at 4:38 PM
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2019 Financial Results and Operational HighlightsOncolytics Biotech® Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
finance.yahoo.com - March 5 at 4:38 PM
ONYN.SG - Oncolytics Biotech Inc. RegisteONYN.SG - Oncolytics Biotech Inc. Registe
finance.yahoo.com - February 29 at 7:34 AM
Study Shows Surprisingly Low Number of Patients Seek Trials to Treat CancerStudy Shows Surprisingly Low Number of Patients Seek Trials to Treat Cancer
www.marketwatch.com - February 26 at 9:37 AM
Agency Taps Australia to Create a Coronavirus Vaccine With Unprecedented SpeedAgency Taps Australia to Create a Coronavirus Vaccine With 'Unprecedented Speed'
www.finanznachrichten.de - January 28 at 12:31 PM
The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics BiotechThe Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech
finance.yahoo.com - January 23 at 4:06 PM
Oncolytics Biotech: A Small But Very Promising Cancer Player In 2020Oncolytics Biotech: A Small But Very Promising Cancer Player In 2020
seekingalpha.com - January 22 at 7:10 AM
Oncolytics Biotech® Announces Publication of an Abstract for the 2020 Gastrointestinal Cancers Symposium Highlighting CEACAM6 as a Potential Prognostic Biomarker Candidate for Pancreatic CancerOncolytics Biotech® Announces Publication of an Abstract for the 2020 Gastrointestinal Cancers Symposium Highlighting CEACAM6 as a Potential Prognostic Biomarker Candidate for Pancreatic Cancer
finance.yahoo.com - January 22 at 7:09 AM
China’s Coronavirus Could Prompt Buying Frenzy in These Biotech StocksChina’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks
247wallst.com - January 21 at 4:06 PM
New Study Indicates Helper Cells May Kill Cancerous TumorsNew Study Indicates 'Helper' Cells May Kill Cancerous Tumors
www.marketwatch.com - January 16 at 1:33 PM
Oncolytics Biotech® Announces Key Opinion Leader Call Conducted by ROTH Capital Partners to Discuss Multiple MyelomaOncolytics Biotech® Announces Key Opinion Leader Call Conducted by ROTH Capital Partners to Discuss Multiple Myeloma
finance.yahoo.com - January 9 at 4:38 PM
Thinking about buying stock in Advanced Micro Devices, GoPro, Oncolytics Biotech, Rite Aid Corp, or Tesla?Thinking about buying stock in Advanced Micro Devices, GoPro, Oncolytics Biotech, Rite Aid Corp, or Tesla?
www.marketwatch.com - January 7 at 4:09 PM
42 Stocks Moving In Thursdays Mid-Day Session42 Stocks Moving In Thursday's Mid-Day Session
www.msn.com - January 2 at 3:46 PM
Oncolytics Biotech Announces Abstract Outlining Potential New Biomarker to be Presented at the 2020 Gastrointestinal Cancers SymposiumOncolytics Biotech Announces Abstract Outlining Potential New Biomarker to be Presented at the 2020 Gastrointestinal Cancers Symposium
www.finanznachrichten.de - December 12 at 7:15 AM
Oncolytics Biotech(R) Announces Abstract Outlining Potential New Biomarker to be Presented at the 2020 Gastrointestinal Cancers SymposiumOncolytics Biotech(R) Announces Abstract Outlining Potential New Biomarker to be Presented at the 2020 Gastrointestinal Cancers Symposium
finance.yahoo.com - December 12 at 7:15 AM
Cancer Drug Revenues Expected to be Largest Share in Pharma MarketCancer Drug Revenues Expected to be Largest Share in Pharma Market
www.marketwatch.com - December 9 at 1:23 PM
Oncolytics Biotech Announces Positive Multiple Myeloma Data Presented at the 61st Annual Meeting & Exposition of the American Society of HematologyOncolytics Biotech Announces Positive Multiple Myeloma Data Presented at the 61st Annual Meeting & Exposition of the American Society of Hematology
www.finanznachrichten.de - December 9 at 8:23 AM
Oncolytics Biotech(R) Announces Positive Multiple Myeloma Data Presented at the 61st Annual Meeting & Exposition of the American Society of HematologyOncolytics Biotech(R) Announces Positive Multiple Myeloma Data Presented at the 61st Annual Meeting & Exposition of the American Society of Hematology
finance.yahoo.com - December 9 at 8:23 AM
Oncolytics Biotech Announces Abstract Published for the 61st Annual Meeting & Exposition of the American Society of HematologyOncolytics Biotech Announces Abstract Published for the 61st Annual Meeting & Exposition of the American Society of Hematology
www.finanznachrichten.de - November 7 at 7:50 AM
Oncolytics Biotech(R) Announces Abstract Published for the 61st Annual Meeting & Exposition of the American Society of HematologyOncolytics Biotech(R) Announces Abstract Published for the 61st Annual Meeting & Exposition of the American Society of Hematology
finance.yahoo.com - November 7 at 7:50 AM
Market Movers: Oncolytics Biotech, Xerox and Office DepotMarket Movers: Oncolytics Biotech, Xerox and Office Depot
www.baystreet.ca - November 6 at 2:48 PM
Oncolytics Biotech(R) to Host Conference Call to Discuss Third Quarter Financial Results and Operational HighlightsOncolytics Biotech(R) to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights
finance.yahoo.com - November 5 at 7:38 AM
Oncolytics Biotech(R) Appoints Experienced Financial and Strategic Leader Leonard Kruimer to Board of DirectorsOncolytics Biotech(R) Appoints Experienced Financial and Strategic Leader Leonard Kruimer to Board of Directors
finance.yahoo.com - October 17 at 7:18 AM
Oncolytics Biotech(R) Presents Clinical Data Highlighting the Effectiveness of Intravenous Delivery to and Replication of Pelareorep in TumorsOncolytics Biotech(R) Presents Clinical Data Highlighting the Effectiveness of Intravenous Delivery to and Replication of Pelareorep in Tumors
finance.yahoo.com - October 15 at 7:56 AM
Oncolytics Biotech, Inc.Oncolytics Biotech, Inc.
www.fool.com - October 12 at 11:52 PM
Oncolytics Biotech(R) Announces Abstract to be Presented at the 34th Annual Meeting of the Society for Immunotherapy of CancerOncolytics Biotech(R) Announces Abstract to be Presented at the 34th Annual Meeting of the Society for Immunotherapy of Cancer
finance.yahoo.com - October 1 at 8:04 AM
Oncolytics Biotech CEO, Matt Coffey, Honored with Scientific Achievement and Innovation Award by BioAlbertaOncolytics Biotech CEO, Matt Coffey, Honored with Scientific Achievement and Innovation Award by BioAlberta
finance.yahoo.com - September 30 at 7:10 AM
Oncolytics Biotech(R) Announces Upcoming Conference ParticipationOncolytics Biotech(R) Announces Upcoming Conference Participation
finance.yahoo.com - September 23 at 7:53 AM
Oncolytics Biotech(R) to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceOncolytics Biotech(R) to Present at the H.C. Wainwright 21st Annual Global Investment Conference
www.finanznachrichten.de - September 5 at 8:48 AM
Oncolytics Biotech(R) to Host Corporate Update Call to Discuss Recent Highlights and Expanded Catalysts and MilestonesOncolytics Biotech(R) to Host Corporate Update Call to Discuss Recent Highlights and Expanded Catalysts and Milestones
finance.yahoo.com - September 4 at 8:36 AM
The Daily Biotech Pulse: Regenerons Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics OfferingThe Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering
www.benzinga.com - August 14 at 4:02 PM
CORRECTION: Oncolytics Biotech(R) Announces Pricing of Its USD $3.7M - CDN $4.9M Public Offering of Common Share and WarrantsCORRECTION: Oncolytics Biotech(R) Announces Pricing of Its USD $3.7M - CDN $4.9M Public Offering of Common Share and Warrants
finance.yahoo.com - August 14 at 4:02 PM
Oncolytics Biotech(R) Announces First Patient Treated in Companys AWARE-1 Window of Opportunity Study of Pelareorep in Breast CancerOncolytics Biotech(R) Announces First Patient Treated in Company's AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer
finance.yahoo.com - April 8 at 8:53 AM
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.